M&A Talks Europe

5. Sanofi spin-off: bidding war over the future of Pharma

30 min · 14. Okt. 2024
Episode 5. Sanofi spin-off: bidding war over the future of Pharma Cover

Beschreibung

In this episode of M&A Talks Europe, we dive into the high-stakes battle between private equity giants for Sanofi’s consumer medicine division, Opella, ultimately won by American CD&R for €15.5 billion. We’ll explore how this deal fits into broader trends in both the pharmaceutical and private equity sectors, Sanofi’s shift to biopharma, and the political uproar in France over healthcare sovereignty because of sale of Doliprane, most popular medicine in France. Tune in to learn more about pharma and carve-out deals!

Kommentare

0

Sei die erste Person, die kommentiert

Melde dich jetzt an und werde Teil der M&A Talks Europe-Community!

Loslegen

2 Monate für 1 €

Dann 4,99 € / Monat · Jederzeit kündbar.

  • Podcasts nur bei Podimo
  • 20 Stunden Hörbücher / Monat
  • Alle kostenlosen Podcasts

Alle Folgen

5 Folgen